Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2026-01-02 @ 5:04 PM
Study NCT ID:
NCT02551432
Status:
COMPLETED
Last Update Posted:
2020-02-10
First Post:
2015-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer
Sponsor:
Seoul National University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-07
First Submit QC Date:
None
Study First Post Date:
2015-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-25
Results First Submit QC Date:
None
Results First Post Date:
2020-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-07
Last Update Post Date:
2020-02-10
Last Update Post Date Type:
ACTUAL